4D Molecular Therapeutics, Inc. Share Price
Stocks
FDMT
US35104E1001
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
20:00:00 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 12.78 USD | -1.16% |
|
+7.85% | +70.40% |
| 10-21 | 4D Molecular Therapeutics, Inc. - Analyst/Investor Day | |
| 10-07 | 4D Molecular Therapeutics Insider Sold Shares Worth $753,937, According to a Recent SEC Filing | MT |
| Market Cap | 705M 632M 583M 528M 986M 67.18B 1B 6.95B 2.77B 35.16B 2.65B 2.59B 111B | P/E 2026 * |
-3.08x | P/E 2027 * | -3.2x |
|---|---|---|---|---|---|
| Enterprise Value | 510M 457M 422M 382M 714M 48.6B 725M 5.03B 2.01B 25.43B 1.92B 1.87B 80.55B | EV / Sales 2026 * |
38.5x | EV / Sales 2027 * | 18x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| FDMT | Delayed | |
CBOE
| FDMT | Real-time |
Last Transcript: 4D Molecular Therapeutics, Inc.
| 1 day | -1.16% | ||
| 1 week | +7.85% | ||
| Current month | -10.69% | ||
| 1 month | -11.80% | ||
| 3 months | +32.99% | ||
| 6 months | +45.06% | ||
| Current year | +70.40% |
| 1 week | 10.62 |  | 13.46 |
| 1 month | 10.62 | | 14.58 |
| Current year | 6.96 | | 16.93 |
| 1 year | 6.96 | | 16.93 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 31/03/2018 |
David Kirn
CEO | Chief Executive Officer | 64 | 11/09/2013 |
Kristian Humer
DFI | Director of Finance/CFO | 51 | 16/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 11/09/2013 |
Charles Theuer
BRD | Director/Board Member | 62 | 30/11/2015 |
Jacob Chacko
BRD | Director/Board Member | 47 | 28/02/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/10/26 | Sell | Founder | -58,333 | 0.1056% | ||
| 16/09/26 | Exercice | Compliance Officer | 4,905 | 0.0089% | ||
| 14/09/26 | Sell | Founder | -58,333 | 0.1056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.16% | +7.85% | +12.01% | +22.06% | 714M | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +82.98% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +103.69% | 53.03B | |
| -1.43% | -1.17% | +26.27% | +52.86% | 45.99B | |
| -0.48% | -2.80% | +18.01% | +117.99% | 42.45B | |
| +0.82% | +1.37% | +227.94% | +922.41% | 40.45B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +88.74% | 34.47B | |
| -2.72% | -0.44% | +22.58% | -5.63% | 24.23B | |
| Average | -0.42% | +3.69% | +48.34% | +149.13% | 39.33B | |
| Weighted average by Cap. | -0.08% | +3.13% | +49.19% | +160.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.26M 11.87M 10.95M 9.91M 18.54M 1.26B 18.84M 131M 52.14M 661M 49.75M 48.69M 2.09B | 20.63M 18.48M 17.05M 15.43M 28.85M 1.96B 29.32M 203M 81.15M 1.03B 77.43M 75.79M 3.26B |
| Net income | -289M -258M -238M -216M -404M -27.48B -410M -2.85B -1.14B -14.38B -1.08B -1.06B -45.55B | -316M -283M -261M -236M -442M -30.11B -449M -3.12B -1.24B -15.76B -1.19B -1.16B -49.92B |
| Net Debt | -195M -175M -161M -146M -273M -18.58B -277M -1.92B -768M -9.73B -732M -717M -30.8B | -334M -299M -276M -250M -467M -31.81B -475M -3.29B -1.31B -16.65B -1.25B -1.23B -52.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$12.78 | -1.16% | 848,889 |
| 28/10/26 | US$12.93 | +8.11% | 1,189,801 |
| 27/10/26 | US$11.96 | +8.43% | 1,134,654 |
| 26/10/26 | US$11.03 | +2.13% | 1,084,578 |
| 23/10/26 | US$10.80 | -8.86% | 996,140 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
